Oncogene, Published online: 13 March 2026; doi:10.1038/s41388-026-03706-y
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation
Oncogene, Published online: 09 March 2026; doi:10.1038/s41388-026-03717-9
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)
Oncogene, Published online: 07 March 2026; doi:10.1038/s41388-026-03709-9
CHD1 is a synthetic lethal vulnerability in MYC-driven breast cancer
Oncogene, Published online: 07 March 2026; doi:10.1038/s41388-026-03712-0
Arginine methylation-dependent stabilization of SUV39H1 promotes breast cancer growth
Oncogene, Published online: 06 March 2026; doi:10.1038/s41388-026-03708-w
Dexamethasone promotes neutrophil ROS-mediated tumor killing through the glucocorticoid receptor
Oncogene, Published online: 06 March 2026; doi:10.1038/s41388-026-03720-0
C-Jun-activated S100A10 promotes malignant progression via in diminishing ubiquitin-dependent degradation of vimentin in gastric cancer
Oncogene, Published online: 06 March 2026; doi:10.1038/s41388-026-03707-x
PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression
Oncogene, Published online: 05 March 2026; doi:10.1038/s41388-026-03713-z
KRAS-extrachromosomal DNA drives intratumoral heterogeneity in gastric cancer
Login